<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2022-02-10</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-2675</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ASSOCIATED PROBLEMS OF CARDIOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СМЕЖНЫЕ ПРОБЛЕМЫ КАРДИОЛОГИИ</subject></subj-group></article-categories><title-group><article-title>Cerebrovascular Accident in a Patient with Polycythemia: a Case Report</article-title><trans-title-group xml:lang="ru"><trans-title>Нарушение мозгового кровообращения у пациента с полицитемией: клинический случай</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Драпкина Оксана Михайловна.</p><p>Москва.</p><p>eLibrary SPIN 4456-1297</p></bio><bio xml:lang="en"><p>Oxana M. Drapkina.</p><p>Moscow.</p><p>eLibrary SPIN 4456-1297</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6330-5264</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алмазова</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Almazova</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алмазова Ильда Исмаиловна.</p><p>Москва.</p><p>eLibrary SPIN 5486-8743</p></bio><bio xml:lang="en"><p>Ilda I. Almazova.</p><p>Moscow.</p><p>eLibrary SPIN 5486-8743</p></bio><email xlink:type="simple">almazovai@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3938-1344</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смирнова Анна Васильевна.</p><p>Москва.</p><p>eLibrary SPIN 8743-3710</p></bio><bio xml:lang="en"><p>Anna V. Smirnova.</p><p>Moscow.</p><p>eLibrary SPIN 8743-3710</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1002-1895</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бернс</surname><given-names>С. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Berns</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бернс Светлана Александровна.</p><p>Москва.</p><p>eLibrary SPIN 4283-3303</p></bio><bio xml:lang="en"><p>Svetlava A. Berns.</p><p>Moscow.</p><p>eLibrary SPIN 4283-3303</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8984-9056</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шепель</surname><given-names>Р. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Shepel</surname><given-names>R. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шепель Руслан Николаевич.</p><p>Москва.</p><p>eLibrary SPIN 3115-0515</p></bio><bio xml:lang="en"><p>Ruslan N. Shepel.</p><p>Moscow.</p><p>eLibrary SPIN 3115-0515</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр терапии и профилактической медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>05</day><month>03</month><year>2022</year></pub-date><volume>18</volume><issue>1</issue><fpage>79</fpage><lpage>84</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Drapkina O.M., Almazova I.I., Smirnova A.V., Berns S.A., Shepel R.N., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Драпкина О.М., Алмазова И.И., Смирнова А.В., Бернс С.A., Шепель Р.Н.</copyright-holder><copyright-holder xml:lang="en">Drapkina O.M., Almazova I.I., Smirnova A.V., Berns S.A., Shepel R.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/2675">https://www.rpcardio.online/jour/article/view/2675</self-uri><abstract><p>Polycythemia vera is not only a clonal disease that causes hematopoietic stem cells, but also a pathology that often leads to thrombotic complications. Thrombosis can have different localization and is clinically manifested by stroke, myocardial infarction, deep vein thrombosis of the lower extremities, pulmonary embolism, thrombosis of the veins of internal organs and other conditions. One of the most formidable thrombotic complications is acute cerebrovascular accident. The heterogeneity of the possible causes of acute cerebrovascular accident requires a careful approach to differential diagnosis for timely diagnosis and individual, pathogenetically grounded selection of means of long-term antithrombotic therapy. The presented clinical case of the development of cerebrovascular accident in a patient with polycythemia vera demonstrates the importance of an informal approach to diagnosis, as well as interdisciplinary interaction for finding the true cause of the development of acute cerebrovascular accident and the appointment of pathogenetically based treatment, aimed, among other things, at the prevention of repeated episodes of acute cerebrovascular accident and others. thrombotic complications.</p></abstract><trans-abstract xml:lang="ru"><p>Истинная полицитемия является не только клональным заболеванием, возникающим на уровне стволовой кроветворной клетки, но и патологией, часто приводящей к тромботическим осложнениям. Тромбозы могут иметь различную локализацию и клинически проявляться инсультом, инфарктом миокарда, тромбозом глубоких вен нижних конечностей, тромбоэмболией легочной артерии, тромбозом вен внутренних органов и другими состояниями. Одним из наиболее грозных тромботических осложнений является острое нарушение мозгового кровообращения (ОНМК). Гетерогенность возможных причин ОНМК требует тщательного подхода к дифференциальной диагностике для своевременного установления диагноза и индивидуального, патогенетически обоснованного подбора длительной антитромботической терапии. Представленный клинический случай развития нарушения мозгового кровообращения у пациента с истинной полицитемией демонстрирует важность неформального подхода к диагностике, а также междисциплинарного взаимодействия для поиска истинной причины развития ОНМК и назначения патогенетически обоснованного лечения, направленного, в том числе, на профилактику повторных эпизодов ОНМК и других тромботических осложнений.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>истинная полицитемия</kwd><kwd>нарушение мозгового кровообращения</kwd><kwd>тромбоз</kwd><kwd>миелопролиферативное заболевание</kwd><kwd>гидроксимочевина</kwd><kwd>ацетилсалициловая кислота</kwd></kwd-group><kwd-group xml:lang="en"><kwd>polycythemia vera</kwd><kwd>cerebrovascular accident</kwd><kwd>thrombosis</kwd><kwd>myeloproliferative disease</kwd><kwd>hydroxyurea</kwd><kwd>acetylsalicylic acid</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Меликян А.Л., Ковригина А.М., Суборцева И.Н., и др. Национальные клинические рекомендации по диагностике и терапии Ph-негативных миелопролиферативных заболеваний (истинная полицитемия, эссенциальная тромбоцитемия, первичный миелофиброз) (редакция 2018 г.). Гематология и Трансфузиология. 2018;63(3):275-315. DOI: 10.25837/HAT.2019.51.88.001.</mixed-citation><mixed-citation xml:lang="en">Melikyan AL, Kovrigina AM, Subortseva IN, et al. National clinical guidelines for diagnosis and therapy of Ph-negative myeloproliferative neoplasms (polycythemia vera, essential thrombocythemia, primary myelofibrosis) (edition 2018). Russian Journal of Hematology and Transfusiology. 2018;63(3):275-315 (In Russ.) DOI: 10.25837/HAT.2019.51.88.001.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2017;92(1):94-108. DOI:10.1002/ajh.24607.</mixed-citation><mixed-citation xml:lang="en">Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2017;92(1):94-108. DOI:10.1002/ajh.24607.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Абдулкадыров К.М., Шуваев В.А., Мартынкевич И.С. Миелопролиферативные новообразования. Санкт-Петербург, Москва: Литерра; 2016.</mixed-citation><mixed-citation xml:lang="en">Abdulkadyrov KM, Shuvaev VA, Martynkevich IS. Myeloproliferative neoplasms. St. Petersburg, Moscow: Literra; 2016 (In Russ)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ. 2020;368:l6983. DOI:10.1136/bmj.l6983.</mixed-citation><mixed-citation xml:lang="en">Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ. 2020;368:l6983. DOI:10.1136/bmj.l6983.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ройтман Е.В., Шабалина А.А., Танашян М.М. Формализованная оценка системной тромбогенности у пациентов с ишемическим инсультом, развившимся на фоне истинной полицитемии. Атеротромбоз. 2020;(2):105-114. DOI:10.21518/2307-1109-2020-2-105-114.</mixed-citation><mixed-citation xml:lang="en">Roitman EV, Shabalina AA, Tanashyan MM. Formalised assessment of systemic thrombo-genicity in patients with Polycythemia vera suffered an ischemic stroke. Atherothrombosis. 2020;(2):105-14 (In Russ.) DOI:10.21518/2307-1109-2020-2-105-114.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tefferi A, Vardiman J. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008;22(1):14-22. DOI:10.1038/sj.leu.2404955.</mixed-citation><mixed-citation xml:lang="en">Tefferi A, Vardiman J. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008;22(1):14-22. DOI:10.1038/sj.leu.2404955.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Абдулкадыров К.М., Шуваев В.А., Мартынкевич И.С. Что нам известно об истинной полицитемии (обзор литературы и собственные данные). Онкогематология. 2015;10(3):28-42. DOI:10.17650/1818-8346-2015-10-3-28-42.</mixed-citation><mixed-citation xml:lang="en">Abdulkadyrov KM, Shuvaev VA, Martynkevich IS. All we know about polycythemia vera: literature review and own experience. Oncohematology. 2015;10(3):28-42 (In Russ.) DOI:10.17650/1818-8346-2015-10-3-28-42.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
